hepatitisbpostvaccinationsurveillance乙型肝炎疫苗接种后的监测.pptxVIP

Introduction of hepatitis B vaccine into NIPs Methods to evaluate impact of hepatitis B vaccination Short-term vs. long-term measure of impact of vaccination Examples of representative nationwide sero-surveys of impact of hepatitis B vaccination Concluding Remarks;Hepatitis B vaccine is the first vaccine against cancer Available since the early 80’s Prevents 0.5 million deaths/year from acute and chronic hepatitis B virus (HBV) infection Recommendation by WHO (1994) Hep B vaccine should be introduced into NIPs: Countries with HBsAg prevalence ?8% by 1995 Global introduction by 1997 South Afric